Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL28749878 | 0.91 | LMNA (0.38) | LMNATSHRALOX12ACHECES2 | |
| Benzene SCHEMBL3120365 | 0.82 | CYP3A4 (0.37) | LMNATSHRACHEPARP1L3MBTL1 | |
| Toluene SCHEMBL29226068 | 0.81 | NQO2 (0.40) | LMNATSHRALOX12ACHECES2 | |
| Aniline SCHEMBL27368335 | 0.81 | TSHR (0.48) | LMNATSHRCYP2D6PARP1NPC1 | |
| Naphthalene SCHEMBL27608457 | 0.80 | CYP2A6 (0.38) | LMNATSHRALOX12CES2CES1 | |
| Acetophenone SCHEMBL28593300 | 0.80 | HPGD (0.52) | LMNATSHRCES2CES1CYP2D6 | |
| Toluene SCHEMBL1360632 | 0.79 | LMNA (0.65) | LMNATSHRALOX12ACHECES2 | |
| Benzene SCHEMBL27536972 | 0.79 | CYP3A4 (0.35) | LMNATSHRACHEPARP1L3MBTL1 | |
| Toluene SCHEMBL11518095 | 0.79 | LMNA (0.65) | LMNATSHRALOX12ACHECES2 | |
| Benzene SCHEMBL28203037 | 0.79 | CYP3A4 (0.35) | LMNATSHRACHEPARP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260084387-A1 | Multilayer Piezoelectret Film Element, Polymeric Porous Sheet, and Method for Manufacturing the Same | HUBEI XIANGYUAN HIGH TECH CO LTD (CN) | 2026-03-26 | — | — | US | disclosed |
| EP-3640248-B1 | AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIJING ADAMADLE BIOTECHNOLOGY LLC (CN) | 2023-08-23 | — | — | EP | disclosed |
| CN-114174269-B | Pyrimidine compounds acting on EGFR and ERBB2 | 华润医药控股有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11352352-B2 | Aminopyrimidine compound, preparation method therefor and use thereof | Beijing Adamadle Biotechnology Limited Liability Company (CN) | 2022-06-07 | — | — | US | disclosed |
| CN-114469913-A | Application of Tilorone in preventing/treating African swine fever virus infection | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 2022-05-13 | — | — | CN | disclosed |
| CN-114174269-A | Pyrimidines acting on EGFR and ERBB2 | 南京明德新药研发有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-214075426-U | Filtration extraction element of p-toluenesulfonylurea | 吉安市海洲医药化工有限公司 | 2021-08-31 | — | — | CN | disclosed |
| CN-214075426-U | Filtration extraction element of p-toluenesulfonylurea | 吉安市海洲医药化工有限公司 | 2021-08-31 | — | — | CN | disclosed |
| CN-213376643-U | P-toluenesulfonylurea synthesizer | 吉安市海洲医药化工有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-213376643-U | P-toluenesulfonylurea synthesizer | 吉安市海洲医药化工有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-213266344-U | Synthesis device of p-toluenesulfonylurea | 吉安市海洲医药化工有限公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-213266344-U | Synthesis device of p-toluenesulfonylurea | 吉安市海洲医药化工有限公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-112121718-A | A centrifugal agitating unit for toluene sulfonylurea | 吉安市海洲医药化工有限公司 | 2020-12-25 | — | — | CN | disclosed |
| CN-112121718-A | A centrifugal agitating unit for toluene sulfonylurea | 吉安市海洲医药化工有限公司 | 2020-12-25 | — | — | CN | disclosed |
| EP-3640248-A1 | AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing Adamadle Biotechnology Limited Liability Company (CN) | 2020-04-22 | — | — | EP | disclosed |
| US-20200087296-A1 | AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing Adamadle Biotechnology Limited Liability Company (CN) | 2020-03-19 | — | — | US | disclosed |
| CN-107541197-B | Intelligent water exploration type water plugging agent for high-temperature horizontal well | 中国石油天然气股份有限公司 | 2020-02-14 | — | — | CN | disclosed |
| EP-0819765-A2 | Reagent for measuring an amount of cholesterol | WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) | 1998-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260084387-A1 | Multilayer Piezoelectret Film Element, Polymeric Porous Sheet, and Method for Manufacturing the Same | PIEZO1, MEF2D, TMEM63A | LMNA 1299/4885TSHR 1302/4885ALOX12 4082/4885 |
| US-20200087296-A1 | AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, WEE2, EGFR | LMNA 4594/4885TSHR 4187/4885ALOX12 826/4885 |
| US-11352352-B2 | Aminopyrimidine compound, preparation method therefor and use thereof | WEE1, WEE2, EGFR | LMNA 4594/4885TSHR 4187/4885ALOX12 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.